-
Signature
-
/s/ Renee Strandness, attorney-in-fact
-
Stock symbol
-
ROKU
-
Transactions as of
-
Sep 1, 2023
-
Transactions value $
-
-$3,712,659
-
Form type
-
4
-
Date filed
-
9/6/2023, 07:02 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
ROKU |
Class A Common Stock |
Options Exercise |
$0 |
+29.3K |
+95.44% |
$0.00 |
60.1K |
Sep 1, 2023 |
Direct |
|
transaction |
ROKU |
Class A Common Stock |
Sale |
-$1.25M |
-15.2K |
-25.25% |
$82.69 |
44.9K |
Sep 5, 2023 |
Direct |
F1 |
transaction |
ROKU |
Class A Common Stock |
Sale |
-$1.14M |
-14.2K |
-31.55% |
$80.58 |
30.7K |
Sep 5, 2023 |
Direct |
F2 |
transaction |
ROKU |
Class A Common Stock |
Sale |
-$1.32M |
-14.2K |
-46.1% |
$92.89 |
16.6K |
Sep 6, 2023 |
Direct |
F2 |
holding |
ROKU |
Class A Common Stock |
|
|
|
|
|
600 |
Sep 1, 2023 |
Charles D. Collier Revocable Trust |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
ROKU |
Restricted Stock Unit |
Options Exercise |
$0 |
-29.3K |
-7.14% |
$0.00 |
381K |
Sep 1, 2023 |
Class A Common |
29.3K |
|
Direct |
F3, F4 |
transaction |
ROKU |
Employee Stock Option (right to buy) |
Award |
$0 |
+2.14K |
|
$0.00 |
2.14K |
Sep 1, 2023 |
Class A Common Stock |
2.14K |
$81.72 |
Direct |
F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: